Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAGN
3576
Magnera Corp
MAGN
$434M
| $754K | ﹤0.01% |
49,805
+2,850
| +6% | +$33K |
|
3577
PUT
SELLAS Life Sciences
SLS
$2.43B
| $754K | ﹤0.01% |
+200,000
| New | +$389K |
|
|
DRUG
3578
Bright Minds Biosciences
DRUG
$776M
| $754K | ﹤0.01% |
9,660
+3,079
| +47% | +$206K |
|
3579
LCNB Corp
LCNB
$285M
| $753K | ﹤0.01% |
45,945
+10,274
| +29% | +$162K |
|
|
AIFC
3580
AI Financial Corp
AIFC
$58.2M
| $752K | ﹤0.01% |
683,961
+21,929
| +3% | +$42.2K |
|
|
FLY
3581
Firefly Aerospace
FLY
$4.45B
| $751K | ﹤0.01% |
33,587
+25,019
| +292% | +$579K |
|
3582
Titan International
TWI
$447M
| $746K | ﹤0.01% |
95,235
+11,666
| +14% | +$91.4K |
|
|
EFSI
3583
Eagle Financial Services Inc
EFSI
$235M
| $744K | ﹤0.01% |
18,697
+719
| +4% | +$26.9K |
|
3584
Meridian
MRBK
$241M
| $743K | ﹤0.01% |
42,279
+1,634
| +4% | +$25.5K |
|
|
TGB
3585
Trekor Metals
TGB
$3.09B
| $742K | ﹤0.01% |
131,032
+108,610
| +484% | +$511K |
|
3586
QuantumScape Corp
QS
$3.8B
| $741K | ﹤0.01% |
71,160
+36,547
| +106% | +$504K |
|
3587
Matrix Service
MTRX
$330M
| $740K | ﹤0.01% |
63,260
+11,839
| +23% | +$149K |
|
|
AVR
3588
Anteris Technologies
AVR
$864M
| $739K | ﹤0.01% |
148,128
+4,289
| +3% | +$19.7K |
|
3589
Genie Energy
GNE
$383M
| $738K | ﹤0.01% |
53,586
+2,464
| +5% | +$36.3K |
|
3590
Willis Lease Finance
WLFC
$1.15B
| $737K | ﹤0.01% |
16,296
+3,207
| +25% | +$138K |
|
3591
Clearwater Paper
CLW
$353M
| $735K | ﹤0.01% |
42,254
+16,159
| +62% | +$298K |
|
3592
Arteris
AIP
$1.4B
| $733K | ﹤0.01% |
47,299
+7,115
| +18% | +$103K |
|
3593
Mitek Systems
MITK
$845M
| $732K | ﹤0.01% |
69,378
+6,678
| +11% | +$63.1K |
|
|
ALX
3594
Alexander's
ALX
$1.41B
| $731K | ﹤0.01% |
3,354
+273
| +9% | +$60.9K |
|
3595
Smith & Wesson
SWBI
$642M
| $729K | ﹤0.01% |
73,892
+6,067
| +9% | +$58.6K |
|
3596
Invivyd
IVVD
$207M
| $729K | ﹤0.01% |
295,120
-138,390
| -32% | -$288K |
|
3597
Ibotta
IBTA
$740M
| $728K | ﹤0.01% |
32,028
+12,044
| +60% | +$325K |
|
3598
Franklin Financial Services
FRAF
$289M
| $727K | ﹤0.01% |
14,488
+3,331
| +30% | +$164K |
|
3599
Conduent
CNDT
$246M
| $726K | ﹤0.01% |
378,052
+16,299
| +5% | +$35.7K |
|
|
DQ
3600
Daqo New Energy
DQ
$998M
| $726K | ﹤0.01% |
24,605
-36,961
| -60% | -$1.13M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.